Russell Investments Group’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
PC
PCM
PHS
TFCM
CCM
Russell Investments Group's CLPT Position: Q2 2026 in Review
Russell Investments Group increased its ClearPoint Neuro (CLPT) stake by 223% in Q2 2026, buying an estimated $66.4K and bringing the position to 7,702 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #3325.
Russell Investments Group first reported a position in CLPT in Q4 2023 and has held it in 11 quarters since. The position peaked at $315K in Q1 2024. 49 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- Russell Investments Group held 7,702 shares of ClearPoint Neuro worth $137K as of Q2 2026.
- Russell Investments Group bought 5,319 ClearPoint Neuro shares in Q2 2026, an estimated $66.4K.
- ClearPoint Neuro made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3325 holding.
- Russell Investments Group first reported a position in ClearPoint Neuro in Q4 2023 and has held it in 11 quarters since.
- Russell Investments Group's ClearPoint Neuro position peaked at $315K in Q1 2024.
- 49 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.